Arkolith/Insider Trading/ZBIO/Form 4/A

Moulder Leon O JR

Chief Executive Officer, DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4/A · filed Sep 17, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
4 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Conversion(C)108K——113K
Sep 16, 2024Conversion(C)48K——161K
Sep 16, 2024Conversion(C)165K——1.3M
Sep 16, 2024Conversion(C)372K——1.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2024Conversion(C)3.2M——0
Sep 16, 2024Conversion(C)419K——0
Sep 16, 2024Conversion(C)941K——0
Sep 16, 2024Conversion(C)1.4M——0
Sep 12, 2024Grant(A)1.5M—$01.5M

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-24-100765) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML